Spire Healthcare Announces New Executive LTIP Awards

Spire Healthcare ( (GB:SPI) ) has shared an announcement.

Spire Healthcare Group PLC has announced the grant of additional performance share awards under its Long Term Incentive Plan (LTIP) to Executive Director Harbant Samra. The awards, reflecting a recent change in his base salary, are set at 200% of his current salary and will vest based on performance conditions related to shareholder return, ROCE, hospital EBIT margin, and operational excellence. This move aligns with the company’s shareholder-approved Remuneration Policy and underscores its commitment to incentivizing leadership performance.

The most recent analyst rating on (GB:SPI) stock is a Buy with a £321.00 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.

Spark’s Take on GB:SPI Stock

According to Spark, TipRanks’ AI Analyst, GB:SPI is a Outperform.

Spire Healthcare’s stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency, despite high leverage and modest net margins. Technical indicators show positive momentum, supporting a favorable outlook. Corporate events contribute positively with strategic initiatives and strong governance, but the high P/E ratio suggests a need for valuation caution.

To see Spark’s full report on GB:SPI stock, click here.

More about Spire Healthcare

Spire Healthcare Group PLC operates in the healthcare industry, providing a range of medical services and facilities. The company focuses on delivering high-quality healthcare services, including surgery, diagnostics, and outpatient care, primarily in the UK market.

Average Trading Volume: 908,683

Technical Sentiment Signal: Sell

Current Market Cap: £836.9M

For detailed information about SPI stock, go to TipRanks’ Stock Analysis page.